Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Pediatr Obes. 2022 Jan 20;17(7):e12892. doi: 10.1111/ijpo.12892

Table 1.

Summary of predominantly human studies of novel factors focusing on studies during the window of lactation and programming outcomes

Bioactive
Component
Author
(Year)
Species
(n)
Milk
Collection
Standardized
Lactation Time
Point(s)
Maternal Influence Infant Outcomes Weakness/Limitations
miRNA Xi (2016) Human (n=86) No 2-5d, 3 mo miRNA-30B, let-7a, miRNA-378 in colostrum & mature milk are negatively correlated with maternal BMI (pre-pregnancy & late pregnancy), weight

Let-7a in mature milk is negative correlated with late pregnancy maternal weight

No miRNA differences with gestational diabetes mellitus or gestational age.
miRNA-30B & miRNA-378 were higher in colostrum for girls No maternal diet data

No infant anthropometrics
Zamanillo (2019) Human (n=59) Yes 1mo, 2mo, 3mo NW mothers had negative correlations between milk miRNAs expression

Leptin/adiponectin levels observed in NW but not in OW/OB mothers
In NW mothers, infant BMI at 2 years negatively correlated with miRNA at 2m (miR-103, miR-17, miR-181a, miR-222, miR-let7c, miR-146b).

No infant growth correlations with OW/OB mothers
No maternal diet data

Infant growth at 2 years & maternal BMI were obtained by maternal recall
Shah (2021) Human (n=60) Yes 1mo & 3mo Decreased miRNA (miR-148a, miR-30b) abundance at 1mo in OW/OB mothers compared to NW mothers miR-184a was negatively associated with infant weight, FM and FFM at 1m

miR-32 was negatively associated with 1m infant weight

miR-30b abundance was positively associated with 1m weight, %fat & fat mass.

No significant associations were observed with 1m milk miRNA & 6m infant anthropometrics, or between 3m milk miRNA and infant anthropometrics at 3m or 6m
No maternal diet data
Lipokines&Signaling lipids Brezinova (2018) Human (n=53) & Mouse No 72 hr PAHSAs levels were positively associated with weight gain in pregnancy.

Obese mothers had lower total PAHSA and 5-PAHSA levels
No outcomes examined No maternal diet data.

No infant outcomes examined
Bruun (2018) Human (n=100) No 4mo Only adjusted for maternal BMI The low weight z-score group had higher concentrations of oleoylethanolamide, steroylethanolamide, palitoylethanolamide vs infants in the high weight z-score.

Lower skinfold thickness & weight gain per day were associated with higher milk steroylethanolamide
No early lactation samples.

No maternal diet data.

Storage techniques altered concentration of N-acylethanolamides.
Wolfs (2021) Human (n=58) Yes 1mo, 3mo, 6mo 12,13-diHOME positively associated with height, however no association with maternal pre-pregnancy BMI or gestational weight gain

12,13-diHOME concentration increased in milk after exercise at 1mo postpartum
12,13-diHOME was positively associated with birth weight for length and BMI z-score, and negatively associated with in BMI & weight for length z-score over the first 6 months of life

12,13-diHOME was negatively associated with subcutaneous and overall adiposity at 1mo

No association between infant sex and milk 12,13-diHOME levels

High milk succinate was associated with lower infant BMI at 6mo
No maternal diet data.
Small molecules & Metabolites Isganaitis (2019) Human (n=35) Yes 1mo, 6mo Maternal BMI was associated with 10 differing metabolites at 1mo

20 differing metabolites at 6mo

1mo, maternal obesity was linked to differences in human milk orotate & 1,5-anhydroglucitol

6mo maternal obesity was associated with increased acylcarnitine, monosaccharide, & 1,5-anhydroglucitol
Adenine positively correlated with infant weight at 1mo, while X-19656 (an unidentified metabolite) was negative correlated

1mo, 5-methylthioadenosine was positively correlated with infant %fat and maternal BMI. No correlations between milk metabolites with infant weight or adiposity and maternal BMI at 6mo
No maternal diet data.
Prentice (2019) Human (n=619) Yes 4-8wks SCFAs were not associated with maternal BMI

Mothers exclusively breastfeeding had higher milk butyrate
Butyrate was negatively associated with infant weight between 3mo-12mo

Milk formic acid levels were negative associated with BMI over the first 2 years of life

Acetate was negatively associated with skinfold thickness at 3mo
No maternal diet data.
Saben (2020) Human (n=159) Yes 2wk, 2mo, 6mo Maternal BMI & %fat positively correlated with amount of human milk monosaccharides & sugar alcohols 6mo milk mannose, lyxitol & shikimic acid showed a positive association with infant fat mass & %fat No maternal diet data.
Ribo (2021) Human (n=143) & Mouse Yes 1mo Did not report maternal influence on milk betaine Human milk betaine concentration was inversely associated with infant weight-for-length z-score at 1mo & 12mo No maternal diet data
In mice supplemented with betaine, a fivefold increase in betaine milk content was observed In mice, early-exposure to betaine in lactation was associated with decreased adiposity & improved glucose homeostasis in adult mice.

Betaine intake transiently increases offspring Akkermansia species during early life, which is linked to lower gut inflammation in mice
Fructose Goran (2017) Human (n=25) Yes 1mo, 6mo Maternal BMI was used as a covariate Milk fructose was associated with high infant body weight, lean mass, FM, weight for length z-score, & bone mineral content at 6mo No maternal diet data.
Berger (2018) Human (n=41) Yes 6 wks HFCS-sweetened beverage increased milk fructose for up to 5 hrs without an impact on milk glucose or lactose. None were collected No infant outcomes

No maternal diet data
Berger (2020) Human (n=88) NA NA No differences in maternal fructose or sugar-sweetened beverage + juice intake based on maternal pre-pregnancy BMI Infant 24mo cognitive development scores were inversely correlated with fructose consumption by their mothers at 1mo postpartum

No association at 6mo postpartum
Homogenous sample (limited to Hispanic mother-infant dyads)

No milk compositional analysis was performed